Skip to main content
Revolution Medicines, Inc. logo

Revolution Medicines, Inc. — Investor Relations & Filings

Ticker · RVMD ISIN · US76155X1000 LEI · 549300JU3X0LBCQ65892 US Professional, scientific and technical activities
Filings indexed 749 across all filing types
Latest filing 2026-04-27 Proxy Solicitation & In…
Country US United States of America
Listing US RVMD

About Revolution Medicines, Inc.

https://www.revmed.com/

Revolution Medicines, Inc. is a clinical-stage precision oncology company dedicated to discovering and developing novel targeted therapies for cancers driven by the RAS pathway. The company's research focuses on creating innovative small molecule inhibitors that target key nodes within the RAS signaling cascade. Its pipeline is built on a platform designed to address various RAS mutations and associated proteins, aiming to provide transformative treatments for patients with RAS-addicted cancers, which have historically been difficult to treat.

Recent filings

Filing Released Lang Actions
DEF 14A - Revolution Medicines, Inc. (0001628171) (Filer)
Proxy Solicitation & Information Statement
2026-04-27 English
8-K - Revolution Medicines, Inc. (0001628171) (Filer)
Regulatory Filings
2026-04-16 English
424B5 - Revolution Medicines, Inc. (0001628171) (Filer)
Prospectus
2026-04-15 English
424B5 - Revolution Medicines, Inc. (0001628171) (Filer)
Prospectus
2026-04-15 English
FWP - Revolution Medicines, Inc. (0001628171) (Subject)
Regulatory Filings
2026-04-15 English
8-K - Revolution Medicines, Inc. (0001628171) (Filer)
Regulatory Filings
2026-04-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.